March, 2023
Read More
The European Biopharmaceutical Tubing Market size is valued at USD 827 million in 2022 and is projected to reach USD 1.47 billion by the end of 2030, registering a growth rate of 8.2%, compounded annually between 2023 and 2030. Globally, the global market size was valued at 3.44 billion in 2022, and it is projected to reach USD 6.01 billion by the end of 2030, with growth at a CAGR of 8.5% over the forecast period from 2023 to 2030.
|
Report Scope |
Report Statistics |
|
MARKET CAGR (%) |
8.2% |
|
Market Segmentation |
By Type, By Application, and By Region |
|
Largest Market |
Germany |
|
Fastest Growing Market |
Germany |
|
Market Insights Covered |
Market sizing, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Regional, and Country Level Analysis, Competitive Landscape, Investment Opportunities |
|
Key Companies Profiled |
W. L. Gore and Associates, Inc. Freudenberg Group, Saint-Gobain Sekurit, RAUMEDIC AG, NewAge Industries, Inc., TEKNI-PLEX, Zeus Industrial Products, Inc., Optinova, NORDSON CORPORATION, DuPont de Nemours, Inc., and Specialty Silicone Products, Inc |
Biopharmaceutical tubing is precisely manufactured to reach the critical requirements of the biopharmaceutical and medical industries. This tubing is made by the extrusion method and is widely used in feeding tubes, drug delivery systems, and peristaltic pumps as well in an extensive range of minimally serious invasive applications, as well as stent delivery systems, urological retrieval devices, and cardiovascular catheters.
The Biopharmaceutical Tubing Market is accredited to a few major driving elements such as the rising aged population globally, and increasing demand for minimally invasive systems. Though, strong government regulatory methods for biopharmaceutical applications are projected to stop the growth of the biopharmaceuticals market throughout the forecast period 2023-2030.
Growing Demand for Minimally Invasive Procedures register Suggestively to the growth of the Market
Minimally invasive medical systems that carry out by injecting a small device or an implant into the human body are gaining increased demand from physicians and patients, supporting the demand for biopharmaceutical tubing products.
Market Segmentation:
By Type:
Among the above segments, the Silicone biopharmaceutical tubing segment generated the highest share in the European market. Further, the silicone market is projected to register the largest growth rate over the period from 2023 to 2030.
By Application:
The pharmaceutical segment registered the highest market share in 2022, and it is projected to remain the largest revenue generator in the European markets by 2030.
USD Analysis opts for intensive primary and secondary research to ensure accurate and reliable data for our clients. Key statistical organizations such as the Europe biopharmaceutical tubing market are the British Heart Foundation (BHF), the European Union (EU), the European Society of Cardiology (ESC), and the Italian Institute of Statistics (ISTAT).
Key global players analyzed in the industry include W. L. Gore and Associates, Inc. Freudenberg Group, Saint-Gobain Sekurit, RAUMEDIC AG, NewAge Industries, Inc., TEKNI-PLEX, Zeus Industrial Products, Inc., Optinova, NORDSON CORPORATION, DuPont de Nemours, Inc., and Specialty Silicone Products, Inc.
North America Biopharmaceutical Tubing Market
Asia Pacific Biopharmaceutical Tubing Market
Middle East and Africa Biopharmaceutical Tubing Market
Latin America Biopharmaceutical Tubing Market
1. Executive Summary
1.1 Introduction to Europe Biopharmaceutical Tubing Markets
1.2 Europe Biopharmaceutical Tubing Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in the Europe Biopharmaceutical Tubing Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Biopharmaceutical Tubing Market Trends in Europe
3.2 Europe Biopharmaceutical Tubing Market Growth Drivers
3.3 Europe Biopharmaceutical Tubing Market Growth Restraints
4 Europe Biopharmaceutical Tubing Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Europe Biopharmaceutical Tubing Market Segmentation- Outlook by Type
5.1 Biopharmaceutical Tubing Market Share Analysis by Type, 2023
5.2 Plastic Biopharmaceutical Tubing Market Outlook to 2030
5.3 Metal Biopharmaceutical Tubing Market Outlook to 2030
5.4 Silicone Biopharmaceutical Tubing Market Outlook to 2030
6. Europe Biopharmaceutical Tubing Market Segmentation- Outlook by Application
6.1 Europe Biopharmaceutical Tubing Market Share Analysis by Application, 2023
6.2 Pharmaceuticals Applications
6.3 Medical Devices Applications
6.4 Research and Development Applications
6.5 Others
7. Europe Biopharmaceutical Tubing Market Outlook and Opportunities to 2030
7.1 Market Snapshot, 2023
7.2 Europe Biopharmaceutical Tubing Market Outlook by Country, 2021 to 2030
7.3 Germany Biopharmaceutical Tubing Market Outlook, 2021 to 2030
7.4 France Biopharmaceutical Tubing Market Outlook, 2021 to 2030
7.5 United Kingdom Biopharmaceutical Tubing Market Outlook, 2021 to 2030
7.6 Spain Biopharmaceutical Tubing Market Outlook, 2021 to 2030
7.7 Italy Biopharmaceutical Tubing Market Outlook, 2021 to 2030
7.8 Other Europe Biopharmaceutical Tubing Market Outlook, 2021 to 2030
8. Profiles of major world Biopharmaceutical Tubing Companies
8.1 W. L. Gore and Associates, Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
8.2 Saint- Gobain Sekurit
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
8.3 Freudenberg Group
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
8.4 RAUMEDIC AG
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
8.5 TEKNI-PLEX
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
8.6 NewAge Industries
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
8.7 Zeus Industrial Products, Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
8.8 Nordson Corp
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
8.9 DuPont de Nemours
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
8.10 Wacker Chemie AG
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
9. Appendix
9.1 Publisher’s Expertise
9.2 List of Tables and Charts
9.3 List of Exhibits
9.4 Legal Disclaimer
Europe Biopharmaceutical Tubing Market will grow at a CAGR of 8.2% by 2030
Global Biopharmaceutical Tubing Market size is projected to reach USD 6.01 billion by the end of 2030.
Some of the primary and secondary methods linked with this research report on the Europe biopharmaceutical tubing market are the British Heart Foundation (BHF), European Union (EU), European Society of Cardiology (ESC), and Italian Institute of Statistics (ISTAT)
Europe Biopharmaceutical Tubing Market is segmented into material types, and applications
The pharmaceutical sub segment registered the highest market share in 2023, and it is projected to be the leading revenue generator over the forecast period